ArticleSao Paulo medical journal = Revista paulista de medicina2026
Depression and sleep disturbances in children and adolescents with familial Mediterranean fever: a prospective case-control study.
Article in Sao Paulo medical journal = Revista paulista de medicina, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFamilial Mediterranean fever (FMF) is a hereditary autoinflammatory disorder characterized by recurrent febrile episodes and serositis.
objectivesThe aim of this study was to assess the impact of FMF on sleep quality in children and adolescents and to explore the relationship between depressive symptoms and sleep disturbances in this patient population. DESIGN AND
settingA prospective case-control study was conducted at a secondary hospital in Istanbul between July 2024 and January 2025.
methodsChildren and adolescents diagnosed with FMF who were followed at a pediatric rheumatology clinic were included. Sleep disturbances were assessed using the Sleep Disturbance Scale for Children (SDSC), and depressive symptoms were evaluated using the Beck Depression Inventory (BDI). Correlations between these scores were analyzed.
resultsThe mean age of the patient group (n = 97) was significantly higher than that of the control group (n = 90) (10.6 ± 2.9 years vs. 9.3 ± 2.4 years; p < 0.001). The median SDSC and BDI scores were significantly higher in the patient group than in the control group (p < 0.05). Analysis of the SDSC subscales indicated that patients with FMF experienced difficulties in sleep initiation and maintenance, sleep-related breathing problems, hyperhidrosis, arousal disturbances, sleep-wake transitions, and excessive daytime somnolence (p < 0.05). No significant differences were found between patient subgroups categorized by MEFV gene mutations in total BDI scores, total SDSC scores, all SDSC subscale scores, or depression severity classes (p > 0.05). Furthermore, no significant correlations were observed between total BDI scores and total SDSC scores or any of the SDSC subscale scores (p > 0.05)..
conclusionChildren and adolescents with FMF had significantly higher levels of depressive symptoms and sleep disturbances than controls.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.